Evoq Remedies Ltd to consider acquisition of Poshan Nutriwell Pvt Ltd, preferential issue

The Board of Directors of Evoq Remedies Limited in their meeting held on today, i.e. Friday, 18th April, 2025 at the Registered Office of the Company, situated at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad - 380 060 which commenced at 3:00 P.M and concluded at 04:15 P.M. has decided to postpone and reschedule the Board Meeting on Friday, 25th April, 2025 at 03:00 P.M., at the registered office of the Company to discuss and consider, issuance of Equity Shares through preferential issue for consideration other than cash i.e., swap of Equity Shares for acquisition of upto 51.00% of paid-up equity shares of M/s. Poshan Nutriwell Private Limited ("PNPL").

The board will also consider raising of funds upto Rs. 99.00 Crores (Rupees Ninety-Nine Crores Only) by way of issue of Warrants (hereinafter referred to as "Convertible Warrants"), through preferential allotment to the person(s) / entity(ies) belonging to "Non-Promoter Category", as per Chapter V of SEBI (ICDR) Regulations, 2018, subject to approval of Shareholders and other authorities concerned.

Shares of Evoq Remedies Limited was last trading in BSE at Rs. 2.96 as compared to the previous close of Rs. 2.91. The total number of shares traded during the day was 4000 in over 1 trades.

The stock hit an intraday high of Rs. 2.96 and intraday low of 2.96. The net turnover during the day was Rs. 11840.00.

Source : Equity Bulls

Keywords

EvoqRemedies INE0JVD01011 Trading Distributors Acquisition ShareSwap PreferentialIssue